It is important to recognize that in many cases the ERα gene expression in ER-negative breast cancer may not be attributed to DNA mutation, but rather acquired from epigenetic aberrations of the ERαpromoter region in ERα-negative breast cancer cells [6, 7]. Here, ESR1 is linked to breast cancer.